Financial Ratios

WARDWIZARD HEALTHCARE LTD.

NSE : NABSE : 512063ISIN CODE : INE048E01013Industry : Finance - InvestmentHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 18.35 (400)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 1818
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-1.27-0.25-2.11-3.200.16
   CEPS(Rs)-1.27-0.25-2.11-3.200.16
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)2.003.273.525.628.82
   Tax Rate(%)-7.640.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)-22.30-4.27-23.44-267.75-5.09
   EBIT Margin(%)-21.19-3.54-22.95-254.146.04
   Pre Tax Margin(%)-21.33-3.72-23.03-255.235.87
   PAT Margin (%)-22.96-3.72-23.03-255.235.87
   Cash Profit Margin (%)-22.96-3.72-23.03-255.235.87
Performance Ratios
   ROA(%)-37.64-5.69-38.71-41.471.67
   ROE(%)-48.06-7.34-46.12-44.251.78
   ROCE(%)-44.34-6.98-45.96-44.061.83
   Asset Turnover(x)1.641.531.680.160.28
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)27.003.864.020.280.34
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.000.000.000.00
   Receivable days0.0063.020.00622.40394.20
   Inventory Days0.000.0015.69121.850.00
   Payable days304.17
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)1.651.300.755.531.74
   EV/Core EBITDA(x)-7.81-36.74-3.28-2.1828.76
   EV/EBIT(x)-7.81-36.74-3.28-2.1828.76
   EV/CE(x)3.352.171.451.130.50
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)-17.63-26.91630.94-52.660.00
   Core EBITDA Growth(%)-393.1088.7333.99-2091.0624.66
   EBIT Growth(%)-393.1088.7333.99-2091.0624.66
   PAT Growth(%)-408.2088.1934.05-2158.0432.15
   EPS Growth(%)-408.1588.1934.04-2157.8932.17
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)1.283.352.849.5318.36
   Quick Ratio(x)1.283.352.548.7218.36
   Interest Cover(x)-143.00-19.33-287.99-231.8335.24
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.